GE HealthCare and Mayo Clinic Launch GEMINI-RT Initiative to Transform Personalized Radiation Therapy
核心洞察
GE HealthCare and Mayo Clinic announced GEMINI-RT, a strategic collaboration aimed at transforming personalized radiation therapy through integration of imaging, AI, and patient monitoring across the cancer care continuum.
The initiative focuses on four key pillars: automation through AI-powered solutions, predictive oncology for personalized treatment decisions, multi-modal therapies combining radiation with emerging treatments, and connected care for remote patient monitoring.
GEMINI-RT builds on the concept of "twinning the patient, personalizing the beam" to deliver truly tailored radiation therapy treatments using Mayo Clinic's clinical expertise and outcomes data combined with GE HealthCare's technological innovation.
GE HealthCare and Mayo Clinic have announced the launch of GEMINI-RT, an ambitious new collaboration designed to transform personalized radiation therapy and cancer care. The initiative, formally known as the GE HealthCare-Mayo Clinic Initiative in Radiation Therapy, builds on decades of collaboration between the two organizations and their original Strategic Radiology Research Collaboration signed in 2023.
The partnership combines Mayo Clinic's world-class clinical and research expertise with GE HealthCare's leading technical and engineering innovation in oncology care and radiation therapy. GEMINI-RT aims to deliver comprehensive, personalized care by exploring the integration of imaging, advanced therapies, dosimetry, and patient monitoring at every step of the patient journey—from detection and diagnosis to treatment and follow-up.
Addressing Growing Cancer Treatment Demand
Radiation therapy serves as a cornerstone of cancer care, utilized in more than 50% of cases worldwide and for over 2 million U.S. patients annually. The rising global cancer incidence, with 19.3 million new cases reported in 2022, continues to drive demand for this critical treatment modality. Through GEMINI-RT, Mayo Clinic and GE HealthCare aim to make personalized radiation therapy more accessible through new initiatives that integrate streamlined, data-driven solutions.
"GEMINI-RT is grounded in the concept of 'twinning the patient, personalizing the beam'—a transformative approach made possible by Mayo Clinic's extensive clinical expertise and outcomes data," said Bryan Traughber, M.D., vice chair, innovation for radiation oncology, Mayo Clinic. "The combination of research and technological acumen could allow us to model individual patient journeys with precision, enabling radiation therapy treatments that are truly tailored to each patient."
Four Strategic Pillars of Innovation
The collaboration will deepen efforts across four strategic areas designed to enhance clinical outcomes, reduce clinician burnout, and accelerate innovation in radiation oncology:
Automation
The initiative will focus on developing AI-powered solutions that can eliminate repetitive tasks and accelerate treatment planning, streamlining workflows for healthcare providers.
Predictive Oncology
GEMINI-RT will harness clinical insights to personalize cancer treatment decisions and improve patient outcomes through data-driven approaches.
Multi-modal Therapies
The collaboration will explore innovative approaches that combine radiation with emerging treatments like targeted drugs and precision heating to deliver more effective care.
Connected Care
Using AI, biomarkers, and sensors, the initiative aims to monitor patients beyond the clinic setting, with the goal of predicting side effects early and supporting treatment at home.
Clinical and Technological Integration
"This effort enables us to collaborate on solutions that are not only leading-edge but also clinically meaningful, helping shape the future of personalized radiation therapy," said Dr. Ben Newton, Global Head of Oncology, GE Healthcare. "By integrating innovative technology and AI across the care continuum, we can improve clinician experience, support high-quality patient care, and help reduce burnout among care teams."
GEMINI-RT research and activities will be based at Mayo Clinic's campus in Rochester, Minnesota, leveraging both organizations' strengths in clinical practice, research, and product development. This research initiative builds on the 2023 strategic radiology research alliance in which GE HealthCare and Mayo Clinic are collaborating on projects in advanced Magnetic Resonance (MR) technologies and techniques, theranostics treatment for cancer, and diagnostic and interventional ultrasound.
The collaboration represents a significant step forward in the evolution of precision medicine in oncology, with the potential to transform how radiation therapy is planned, delivered, and monitored for cancer patients worldwide.